Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes-A meta-analysis

被引:30
作者
Xu, Kuanfeng [1 ]
Zha, Min [1 ]
Wu, Xiaohong [1 ]
Yu, Zhangbin [2 ]
Yu, Rongbin [3 ]
Xu, Xinyu [1 ]
Chen, Heng [1 ]
Yang, Tao [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Dept Pediat, Nanjing 21004, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 210029, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
SLC30A8; Type; 2; diabetes; 1; Impaired glucose tolerance; Meta-analysis; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; RISK LOCI; CDKAL1; HHEX; POPULATION; CDKN2A/B; IGF2BP2; HETEROGENEITY;
D O I
10.1016/j.diabres.2010.11.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To investigate the association of solute carrier family 30 member 8 (SLC30A8) rs13266634 C/T polymorphism with type 2 diabetes (T2DM), impaired glucose tolerance (IGT), and type 1 diabetes (T1DM). Methods: We searched all the publications about the association between SLC30A8 and diabetes from PubMed, and evaluated the association between SLC30A8 rs13266634 C/T polymorphism and T2DM, IGT and T1DM, respectively, by meta-analysis of all the validated studies. Allelic and genotypic comparisons between cases and controls were evaluated. Results: Thirty six studies were included in the meta-analysis: 31 studies were analysed for rs13266634 C/T polymorphism with T2DM, 3 studies with IGT and 4 studies with T1DM. The pooled odds ratios (ORs) for allelic and genotypic comparisons (including additive model, co-dominant model, dominant model and recessive model) showed that rs13266634 C/T polymorphism was significantly associated with increased T2DM risk: OR = 1.15, 95% confidence interval (CI) = 1.13-1.17, P < 0.001, P-heterogeneity = 0.041, OR = 1.34, 95% CI = 1.26-1.41, P < 0.001, P-heterogeneity = 0.908, OR = 1.20, 95% CI = 1.16-1.24, P < 0.001, Pheterogeneity = 0.699, and OR = 1.23, 95% CI = 1.17-1.30, P < 0.001, P-heterogeneity = 0.801, respectively. In subgroup analyses, we found that rs13266634 C/T polymorphism was associated with T2DM risk both in Asian and European subgroup (P < 0.001), but not in African (P > 0.05). And the pooled odds ratio (OR) for allelic frequency comparison showed that rs13266634 C/T polymorphism was also significantly associated with IGT: OR = 1.15, 95% CI = 1.06-1.26, P < 0.001, Pheterogeneity = 0.364. Meanwhile, our meta-analysis did not suggest that rs13266634 C/T polymorphism was associated with T1DM risk (P > 0.05): OR = 1.02, 95% CI = 0.98-1.06, P = 0.328, Pheterogeneity = 0.488 for allelic frequency comparison. Conclusions: Our meta-analysis results revealed the significant association between rs13266634 C/T polymorphism and T2DM and IGT, but did not support the association between this polymorphism and T1DM. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 50 条
  • [41] Association of SLC30A8, CDKAL1, TCF7L2 and HHEX Gene Polymorphisms with Type 2 Diabetes in the Population of North East India
    A. Bhowmick
    P. Sarkar
    M. P. Baruah
    D. Bodhini
    V. Radha
    V. Mohan
    S. Banu
    Cytology and Genetics, 2020, 54 : 165 - 172
  • [42] Protective effect of the rare variant rs13266634C/T of the SLC30A8 gene in the genetic background of the development of type 2 diabetes in Turkish population (Apr, 10.1007/s13410-023-01195-3, 2023)
    Erkoc-Kaya, Dudu
    Arikoglu, Hilal
    Korez, Kazim Muslu
    Ipekci, Suleyman Hilmi
    Baldane, Suleyman
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (06) : 1061 - 1061
  • [43] Association of SLC30A8, CDKAL1, TCF7L2 and HHEX Gene Polymorphisms with Type 2 Diabetes in the Population of North East India
    Bhowmick, A.
    Sarkar, P.
    Baruah, M. P.
    Bodhini, D.
    Radha, V.
    Mohan, V.
    Banu, S.
    CYTOLOGY AND GENETICS, 2020, 54 (02) : 165 - 172
  • [44] Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes
    Chen, Guanjie
    Shriner, Daniel
    Zhang, Jianhua
    Zhou, Jie
    Adikaram, Poorni
    Doumatey, Ayo P.
    Bentley, Amy R.
    Adeyemo, Adebowale
    Rotimi, Charles N.
    PLOS ONE, 2022, 17 (06):
  • [45] Association of Genetic Variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 Diabetes Mellitus in Tunisia
    Kifagi, Chamseddine
    Makni, Kaouthar
    Boudawara, Mouhamed
    Mnif, Fatma
    Hamza, Naziha
    Abid, Mouhamed
    Granier, Claude
    Ayadi, Hammadi
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011, 15 (06) : 399 - 405
  • [46] Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes
    Brorsson, Caroline
    Vaziri-Sani, Fariba
    Bergholdt, Regine
    Eising, Stefanie
    Nilsson, Anita
    Svensson, Jannet
    Lernmark, Ake
    Pociot, Flemming
    AUTOIMMUNITY, 2011, 44 (02) : 107 - 114
  • [47] Risk of type 2 diabetes mellitus and cardiovascular complications in KCNJ11, HHEX and SLC30A8 genetic polymorphisms carriers: A case-control study
    Das Aka, Tutun
    Saha, Urmi
    Shati, Sayara Akter
    Aziz, Md Abdul
    Begum, Mobashera
    Hussain, Md Saddam
    Millat, Md Shalahuddin
    Uddin, Mohammad Sarowar
    Islam, Mohammad Safiqul
    HELIYON, 2021, 7 (11)
  • [48] Meta-analysis of the family-based association between the PTPN22 C1858T polymorphism and Type 1 diabetes
    Lee, Young Ho
    Song, Gwan Gyu
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (01) : 211 - 215
  • [49] Association of the interleukin-10-592A/C,-1082G/A and-819T/C gene polymorphisms with type 2 diabetes: A meta-analysis
    Li, Jing
    Wu, Song
    Wang, Ming-Rui
    Wang, Ting-Ting
    Zhu, Ji-Min
    GENE, 2013, 521 (02) : 211 - 216
  • [50] SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
    Yazdi, Kazem Vatankhah
    Kalantar, Seyed Mehdi
    Houshmand, Massoud
    Rahmanian, Masoud
    Manaviat, Masoud Reza
    Jahani, Mohammad Reza
    Kamalidehghan, Behnam
    Almasi-Hashiani, Amir
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 897 - 906